These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25828419)

  • 21. Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010-2018.
    Rückert-Eheberg IM; Nolde M; Ahn N; Tauscher M; Gerlach R; Güntner F; Günter A; Meisinger C; Linseisen J; Amann U; Baumeister SE
    Eur J Clin Pharmacol; 2022 Apr; 78(4):657-667. PubMed ID: 34877614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and associations of the use of proton-pump inhibitors in nursing homes: a cross-sectional study.
    de Souto Barreto P; Lapeyre-Mestre M; Mathieu C; Piau C; Bouget C; Cayla F; Vellas B; Rolland Y
    J Am Med Dir Assoc; 2013 Apr; 14(4):265-9. PubMed ID: 23211534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of nonformulary use of PPIs and excess drug cost in a Veterans Affairs population.
    Ajumobi AB; Vuong R; Ahaneku H
    J Manag Care Pharm; 2012; 18(1):63-7. PubMed ID: 22235956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.
    Hedberg J; Sundström J; Thuresson M; Aarskog P; Oldgren J; Bodegard J
    J Intern Med; 2013 Oct; 274(4):371-80. PubMed ID: 23800296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Proton pump inhibitors: impact of professional practice evaluation on prescriptions pertinence].
    Fuzier R; Maguès JP; Dupuis E; Pomiès S; Segui S; Sénard JM
    Ann Fr Anesth Reanim; 2011 Nov; 30(11):814-8. PubMed ID: 21981846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based and unlicensed indications for proton pump inhibitors and patients' preferences for discontinuation: a pilot study in a sample of Italian community pharmacies.
    Pasina L; Urru SA; Mandelli S; Giua C; Minghetti P;
    J Clin Pharm Ther; 2016 Apr; 41(2):220-3. PubMed ID: 26931180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 30-month evaluation of the effects on the cost and utilization of proton pump inhibitors from adding omeprazole OTC to drug benefit coverage in a state employee health plan.
    West DS; Johnson JT; Hong SH
    J Manag Care Pharm; 2006; 12(1):25-32. PubMed ID: 16420105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Appropriate proton pump inhibitor use among older adults: a retrospective chart review.
    George CJ; Korc B; Ross JS
    Am J Geriatr Pharmacother; 2008 Dec; 6(5):249-54. PubMed ID: 19161927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study.
    Jonasson C; Tvete IF; Hatlebakk JG
    Scand J Gastroenterol; 2013 Sep; 48(9):1010-7. PubMed ID: 23859491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of age, gender, ethnicity, socioeconomic status and region on dispensing of CVD secondary prevention medication in New Zealand: the Atlas of Health Care Variation CVD cohort (VIEW-1).
    Kerr A; Exeter D; Hanham G; Grey C; Zhao J; Riddell T; Lee M; Jackson R; Wells S
    N Z Med J; 2014 Aug; 127(1400):39-69. PubMed ID: 25145366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twenty-year trends in benzodiazepine dispensing in the Australian population.
    Islam MM; Conigrave KM; Day CA; Nguyen Y; Haber PS
    Intern Med J; 2014 Jan; 44(1):57-64. PubMed ID: 24450521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands.
    van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
    Aliment Pharmacol Ther; 2009 Mar; 29(5):571-9. PubMed ID: 19035978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing the cost of proton pump inhibitors by adopting best practice.
    Hughes JD; Tanpurekul W; Keen NC; Ee HC
    Qual Prim Care; 2009; 17(1):15-21. PubMed ID: 19281670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti-inflammatory drug users.
    Dries AM; Richardson P; Cavazos J; Abraham NS
    Aliment Pharmacol Ther; 2009 Sep; 30(6):652-61. PubMed ID: 19573167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rising rates of proton pump inhibitor prescribing in US emergency departments.
    Mazer-Amirshahi M; Mullins PM; van den Anker J; Meltzer A; Pines JM
    Am J Emerg Med; 2014 Jun; 32(6):618-22. PubMed ID: 24721025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.
    Thomas L; Culley EJ; Gladowski P; Goff V; Fong J; Marche SM
    J Manag Care Pharm; 2010 Mar; 16(2):122-9. PubMed ID: 20178397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uses of proton pump inhibitors and hypomagnesemia.
    Gau JT; Yang YX; Chen R; Kao TC
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pump inhibitors prescribing following the introduction of generic drugs.
    Cammarota S; Bruzzese D; Sarnelli G; Citarella A; Menditto E; Riegler S; Savino IG; Vozzella L; Piccinocchi G; Napoli L; Arpino G; Cuomo R
    Eur J Clin Invest; 2012 Oct; 42(10):1068-78. PubMed ID: 22681176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appropriateness of the use of proton pump inhibitors in the Emergency Department of a Spanish university hospital.
    Granero-Melcon B; Morrás I; Galán-DeJuana M; Abad-Santos F
    Rev Esp Enferm Dig; 2018 Dec; 110(12):755-761. PubMed ID: 30362359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.